CELC Logo

Celcuity Inc. (CELC) 

NASDAQ$10.03
Market Cap
$372.41M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
509 of 924
Rank in Industry
294 of 527

CELC Insider Trading Activity

CELC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$23,0794100

Related Transactions

Buller Richard Edirector0$04$23,079$-23,079

About Celcuity Inc.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Insider Activity of Celcuity Inc.

Over the last 12 months, insiders at Celcuity Inc. have bought $0 and sold $23,079 worth of Celcuity Inc. stock.

On average, over the past 5 years, insiders at Celcuity Inc. have bought $850,494 and sold $114,142 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $103,187 was made by Furcht Leo (director) on 2023‑05‑22.

List of Insider Buy and Sell Transactions, Celcuity Inc.

2024-10-23SaleBuller Richard Edirector
350
0.0009%
$16.25$5,688-20.26%
2024-08-23SaleBuller Richard Edirector
350
0.0009%
$16.95$5,933-24.58%
2024-06-21SaleBuller Richard Edirector
350
0.0011%
$15.68$5,488-7.97%
2024-04-24SaleBuller Richard Edirector
350
0.0011%
$17.06$5,971-11.33%
2024-02-21SaleBuller Richard Edirector
350
0.0014%
$14.15$4,953+9.41%
2023-12-20SaleBuller Richard Edirector
350
0.0015%
$14.37$5,030+9.12%
2023-12-15SaleDalvey Daviddirector
2,940
0.0121%
$14.57$42,847+6.71%
2023-12-14SaleDalvey Daviddirector
5,000
0.0206%
$14.75$73,752+6.35%
2023-12-13SaleDalvey Daviddirector
5,000
0.0202%
$14.50$72,500+6.32%
2023-12-12SaleDalvey Daviddirector
2,060
0.0085%
$14.61$30,089+9.27%
2023-12-08SaleDalvey Daviddirector
5,000
0.0207%
$15.00$75,000+6.50%
2023-12-07SaleDalvey Daviddirector
5,000
0.0207%
$14.85$74,250+6.14%
2023-10-25SaleBuller Richard Edirector
350
0.0016%
$10.23$3,581+55.32%
2023-08-30SaleBuller Richard Edirector
350
0.0015%
$9.28$3,248+58.21%
2023-08-23SaleBuller Richard Edirector
300
0.0013%
$9.82$2,946+46.64%
2023-06-23SaleBuller Richard Edirector
300
0.0014%
$11.79$3,537+25.70%
2023-05-23SaleBuller Richard Edirector
75
0.0003%
$11.10$833+19.55%
2023-05-22SaleBuller Richard Edirector
100
0.0005%
$10.50$1,050+22.55%
2023-05-22PurchaseFurcht Leodirector
10,000
0.0449%
$10.32$103,187+22.55%
2023-05-19SaleBuller Richard Edirector
250
0.0011%
$9.85$2,463+23.81%
Total: 42
*Gray background shows transactions not older than one year

Insider Historical Profitability

16.77%
Buller Richard Edirector
6681
0.018%
$67,010.43026
Sullivan Brian F.Chief Executive Officer
3016643
8.1246%
$30.26M10+9.33%
Dalvey Daviddirector
225000
0.606%
$2.26M06
NIGON RICHARDdirector
96032
0.2586%
$963,200.9670+17.87%
Furcht Leodirector
10250
0.0276%
$102,807.5010+22.55%
Murphy Polly A.director
5000
0.0135%
$50,150.0010+10.68%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$109,415,500
33
18.13%
$353.41M
$41,446,394
27
12.91%
$340.18M
$73,222,926
18
60.19%
$406.4M
$14,865,077
18
-28.56%
$389.16M
$276,750,010
16
-7.95%
$385.21M
$46,442,839
15
-20.05%
$391.15M
$7,254,955
14
20.70%
$359.58M
$18,945,106
14
-27.94%
$352.6M
$65,355,913
13
-3.42%
$367.14M
$1,037,470
13
78.00%
$381.85M
$81,667,942
12
-57.54%
$360.65M
Celcuity Inc.
(CELC)
$3,073,199
10
16.77%
$372.41M
$52,263,118
10
-6.89%
$406.76M
$4,706,376
8
42.30%
$347.52M
$3,677,917
5
10.19%
$400.55M
$51,588,185
5
19.18%
$364M
$79,238,118
4
-26.47%
$394.44M
$8
2
28.83%
$351.07M
$960,000
2
15.91%
$404.49M

CELC Institutional Investors: Active Positions

Increased Positions55+46.61%4M+14.43%
Decreased Positions50-42.37%4M-14.44%
New Positions20New1MNew
Sold Out Positions21Sold Out927,186Sold Out
Total Postitions123+4.24%30M-0.02%

CELC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Bvf Inc/Il$32,684.009.37%3.47M00%2024-12-31
Baker Bros. Advisors Lp$25,259.007.24%2.68M+803,575+42.86%2024-12-31
Soleus Capital Management, L.P.$24,189.006.93%2.57M+1M+105.97%2024-12-31
Perceptive Advisors Llc$22,276.006.39%2.36M00%2024-12-31
Blackrock, Inc.$20,549.005.89%2.18M+368,616+20.36%2024-12-31
Vanguard Group Inc$15,578.004.47%1.65M+24,429+1.5%2024-12-31
Eventide Asset Management, Llc$11,935.003.42%1.27M-269,347-17.55%2024-12-31
Samlyn Capital, Llc$11,803.003.38%1.25M-39,342-3.05%2024-12-31
Nea Management Company, Llc$11,788.003.38%1.25M00%2024-12-31
Saturn V Capital Management Lp$10,031.002.88%1.06M+117,448+12.41%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.